US Broker Ratings

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: A 38.76% Potential Upside in Cutting-Edge Gene Editing

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering biotechnology firm specializing in gene editing, presents a compelling investment opportunity with a potential upside of 38.76%. As a..

RxSight, Inc. (RXST) Stock Analysis: Evaluating Growth Potential Amidst Market Challenges

RxSight, Inc. (NASDAQ: RXST), a pioneering name in the healthcare sector, specifically in medical devices, is drawing investor attention with its innovative approach to enhancing post-cataract..

Inventiva S.A. (IVA) Stock Analysis: Unpacking a 227% Potential Upside in Biotech

Inventiva S.A. – American Depositary Shares (IVA) is a name that has been turning heads in the biotech sector. Trading on the healthcare-focused biotechnology industry, Inventiva..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 58% Potential Upside with Strong Buy Ratings

Castle Biosciences, Inc. (NASDAQ: CSTL), a burgeoning player in the healthcare sector, is making waves in the diagnostics and research industry, particularly with its innovative molecular..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Can This Biotech Innovator Turn Challenges into Opportunities?

Fortrea Holdings Inc. (NASDAQ: FTRE), a nascent player in the healthcare sector, is navigating the complexities of its role as a contract research organization. With a..

Zenas BioPharma, Inc. (ZBIO)

⚠️ No article content returned.

..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a Promising 105.95% Upside Potential

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a burgeoning player in the biotechnology sector, offers an intriguing opportunity for investors seeking exposure to the healthcare space. With a..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Biotech Gem with a 351.84% Potential Upside

Investors seeking opportunities in the biotechnology sector should keep a keen eye on Tectonic Therapeutic, Inc. (NASDAQ: TECX). With a market capitalization of $330.27 million, Tectonic..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Growth in Healthcare Diagnostics with a Potential 11% Upside

Fulgent Genetics, Inc. (NASDAQ: FLGT) is a name that continues to capture the attention of investors in the Healthcare sector, particularly within the Diagnostics & Research..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Eyeing a 26% Upside with Precision Therapies in Focus

Cogent Biosciences, Inc. (NASDAQ: COGT) is making waves in the biotechnology sector with its focused approach on precision therapies for genetically defined diseases. As an investor,..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Challenges with a 14.61% Upside Potential

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a fascinating case for investors interested in the healthcare sector, particularly within the biotechnology industry. Headquartered in San Diego,..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a Potential 137% Upside in the Biotech Arena

REGENXBIO Inc. (NASDAQ: RGNX) is a clinical-stage biotechnology company making waves in the healthcare sector with its innovative gene therapy solutions. Positioned at the forefront of..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A Promising Biotech with 53% Upside Potential

Sana Biotechnology, Inc. (NASDAQ: SANA) stands out in the competitive biotechnology sector, primarily due to its innovative approach to cell engineering and a significant upside potential..

Butterfly Network, Inc. (BFLY): Investor Outlook with a Potential 41% Upside

Butterfly Network, Inc. (NASDAQ: BFLY), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with a promising potential..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Biotech’s 196% Upside Potential Captures Investor Attention

Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with a promising outlook for investors. Despite recent challenges, the..

iRadimed Corporation (IRMD) Stock Analysis: Navigating Growth with a 23.75% Return on Equity

iRadimed Corporation (IRMD) is carving a notable niche in the healthcare sector, specifically within the medical devices industry. Headquartered in Winter Springs, Florida, this U.S.-based company..

Community Health Systems, Inc. (CYH) Stock Analysis: Will Healthcare Challenges Turn into a 16% Upside?

Community Health Systems, Inc. (NYSE: CYH), a stalwart in the healthcare sector, operates a network of acute care hospitals across the United States. With a current..

Xencor, Inc. (XNCR) Stock Analysis: Biotech Innovator with 72% Upside Potential

Xencor, Inc. (NASDAQ: XNCR) is a promising player in the biotechnology sector, particularly for investors with an appetite for growth and innovation in healthcare. With a..

Bioventus Inc. (BVS) Stock Analysis: A Healthcare Gem with 113% Potential Upside

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, has emerged as a compelling opportunity for investors seeking exposure in the medical devices industry...

Neuropace, Inc. (NPCE) Investor Outlook: Analyst Consensus Points to a 57% Potential Upside

Neuropace, Inc. (NASDAQ: NPCE), a pioneering company in the medical devices sector, commands attention with its innovative approach to treating drug-resistant focal epilepsy. Based in Mountain..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds